Literature DB >> 9626722

Capacity limitations in short-term memory in schizophrenia: tests of competing hypotheses.

T E Goldberg1, K J Patterson, Y Taqqu, K Wilder.   

Abstract

BACKGROUND: Capacity limitation theories have proved to be surprisingly resilient in characterizing some of the cognitive deficits in schizophrenia. However, this perspective has not generally been applied to short-term verbal memory tasks. We explored this issue by first attempting to ascertain if gross misallocations of processing resources might explain impairments in short-term memory in schizophrenia on a classic digit span task and in a second study by attempting to determine what effects delay and memory set size had on a divided attention short-term verbal memory paradigm.
METHODS: In the first study 16 patients with schizophrenia and 21 normal controls received 40 trials of a three digit task and 20 trials of a six digit span task. As the absolute number of digits presented and duration of presentation in two conditions were identical, subjects thus had equivalent 'opportunities' to make errors if distraction, in the sense of misallocation of cognitive resources, were at the root of poor performance. In the second study 15 patients with schizophrenia and 15 normal controls were tested in conditions in which two, four or six words were presented and in which rehearsal was prevented by an interference task (colour naming) for delays of 5, 10 or 15 s.
RESULTS: Patients had disproportionate difficulty on the six digit rather than the three digit condition, suggesting that deficits in the verbal working memory short-term store may not be the result of attentional factors. In the second study, patients' performance was differentially worsened by the interference task, by memory set size (i.e. a capacity limitation) and by delay, a measure of decay rate.
CONCLUSIONS: In concert, these studies demonstrate that schizophrenia patients have difficulties on verbal short-term memory span tasks not because of misallocation of resources, but rather because of limitations in 'representational capacity' and maintenance of information over delays.

Entities:  

Mesh:

Year:  1998        PMID: 9626722     DOI: 10.1017/s0033291797006429

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  12 in total

1.  Premorbid neurocognitive functioning in schizophrenia spectrum disorder.

Authors:  Holger J Sørensen; Erik L Mortensen; Josef Parnas; Sarnoff A Mednick
Journal:  Schizophr Bull       Date:  2006-01-25       Impact factor: 9.306

2.  Influence of emotional processing on working memory in schizophrenia.

Authors:  Karla Becerril; Deanna Barch
Journal:  Schizophr Bull       Date:  2010-02-22       Impact factor: 9.306

3.  Differential effects of paced and unpaced responding on delayed serial order recall in schizophrenia.

Authors:  S Kristian Hill; Ginny B Griffin; James C Houk; John A Sweeney
Journal:  Schizophr Res       Date:  2011-06-25       Impact factor: 4.939

Review 4.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

5.  Impairment of working memory maintenance and response in schizophrenia: functional magnetic resonance imaging evidence.

Authors:  Naomi R Driesen; Hoi-Chung Leung; Vincent D Calhoun; R Todd Constable; Ralitza Gueorguieva; Ralph Hoffman; Pawel Skudlarski; Patricia S Goldman-Rakic; John H Krystal
Journal:  Biol Psychiatry       Date:  2008-09-27       Impact factor: 13.382

6.  An fMRI study of working memory in first-degree unaffected relatives of schizophrenia patients.

Authors:  Shashwath A Meda; Manish Bhattarai; Nicholas A Morris; Robert S Astur; Vince D Calhoun; Daniel H Mathalon; Kent A Kiehl; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2008-08-03       Impact factor: 4.939

7.  The amphetamine sensitization model of schizophrenia: relevance beyond psychotic symptoms?

Authors:  Daria Peleg-Raibstein; Benjamin K Yee; Joram Feldon; Jonas Hauser
Journal:  Psychopharmacology (Berl)       Date:  2009-03-27       Impact factor: 4.530

Review 8.  A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia.

Authors:  Martin Sarter; Vicente Martinez; Rouba Kozak
Journal:  Psychopharmacology (Berl)       Date:  2008-07-10       Impact factor: 4.530

Review 9.  Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia.

Authors:  Robert W Buchanan; Robert Freedman; Daniel C Javitt; Anissa Abi-Dargham; Jeffrey A Lieberman
Journal:  Schizophr Bull       Date:  2007-07-19       Impact factor: 9.306

10.  Convergent approaches for defining functional imaging endophenotypes in schizophrenia.

Authors:  Godfrey D Pearlson; Vince D Calhoun
Journal:  Front Hum Neurosci       Date:  2009-11-24       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.